Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.07
Bid: 0.065
Ask: 0.075
Change: 0.00 (0.00%)
Spread: 0.01 (15.385%)
Open: 0.07
High: 0.07
Low: 0.07
Prev. Close: 0.07
RBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Reabold Resources PLC

23 Jul 2020 12:00

RNS Number : 9143T
Reabold Resources PLC
23 July 2020
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Reabold Resources plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Reabold Resources plc ("Reabold"), being the offeror

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

22 July 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

0.1 pence ordinary shares ("Ordinary Shares")

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

0.00

Nil

0.00

(2) Cash-settled derivatives:

 

Nil

0.00

Nil

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0.00

Nil

0.00

 

TOTAL:

Nil

0.00

Nil

0.00

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

Interests held by directors of, and persons acting in concert with, Reabold:

 

Name

Ordinary Shares

%

Jeremy Edelman*

169,000,000

2.50%

Sachin Oza

16,637,058

0.25%

Stephen Williams

12,222,111

0.18%

Michael Felton

8,386,431

0.12%

Anthony Samaha

1,000,000

0.01%

Oza A Esq & M Mrs**

234,519,774

3.48%

Total

441,765,374

6.55%

 

Notes:

* includes 144,000,000 Ordinary Shares held by Saltwind Enterprises Ltd, a company connected with Jeremy Edelman.

** close relatives of Sachin Oza.

 

 

Interests held as options over Ordinary Shares by directors of Reabold:

 

Name

Ordinary Shares

Vesting Date

Expiry Date

Exercise Price (per share)

Sachin Oza

20,000,000

19/03/2018

19/03/2022

0.60p

20,000,000

14/03/2019

19/03/2022

0.90p

20,000,000

14/09/2019

19/03/2022

1.20p

30,000,000

19/10/2017

19/10/2021

0.50p

30,000,000

19/10/2018

19/10/2021

0.75p

30,000,000

19/04/2019

19/10/2021

1.00p

Total

150,000,000

Stephen Williams

20,000,000

19/03/2018

19/03/2022

0.60p

20,000,000

14/03/2019

19/03/2022

0.90p

20,000,000

14/09/2019

19/03/2022

1.20p

30,000,000

19/10/2017

19/10/2021

0.50p

30,000,000

19/10/2018

19/10/2021

0.75p

30,000,000

19/04/2019

19/10/2021

1.00p

Total

150,000,000

Anthony Samaha

5,000,000

19/03/2018

19/03/2022

0.60p

10,000,000

19/10/2017

19/10/2021

0.50p

Total

15,000,000

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

23 July 2020

Contact name:

Anthony Samaha

Telephone number:

c/o Strand Hanson Limited

+44 (0)20 7409 3494

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEESEAFSDESSEIW
Date   Source Headline
12th Jun 20132:22 pmRNSResult of AGM
17th May 20137:00 amRNSPosting of Shareholder Circular
21st Dec 20124:56 pmRNSFinal Results
21st Dec 20124:53 pmRNSRestoration to Trading, etc.
21st Dec 20124:52 pmRNSHalf Yearly Report
19th Dec 201212:52 pmRNSResult of General Meeting etc.
3rd Dec 20125:48 pmRNSNotice of General Meeting
17th Aug 20125:00 pmRNSChange of Adviser
23rd Jul 201212:17 pmRNSAppointment of Administrators
20th Jul 201212:56 pmRNSNotice of Intention to Appoint Administrators
16th Jul 20127:00 amRNSSale of bChannels Ltd and Second2 Ltd
26th Jun 201210:00 amRNSSuspension - Adventis Group Plc
26th Jun 201210:00 amRNSStatement re. Suspension
19th Jun 201210:43 amRNSFurther Update on sale of Technology division
13th Jun 20121:01 pmRNSUpdate on proposed sale of Technology division
10th May 20127:00 amRNSUpdate
1st Feb 20127:00 amRNSChange of Name of Nominated Adviser and Broker
11th Jan 20127:00 amRNSDisposal
7th Dec 20117:00 amRNSDisposal
28th Sep 20117:00 amRNSHalf Yearly Report
19th Sep 20117:00 amRNSOrderly wind down of Adventis Health
30th Jun 20116:15 pmRNSResult of AGM
23rd Jun 20117:00 amRNSNPA Appeal Upheld
6th Jun 201111:14 amRNSPosting of Annual Report and Notice of AGM
27th May 20117:00 amRNSPreliminary Results - year ended 31 December 2010
12th May 20112:54 pmRNSDirectorate Change
10th May 20117:00 amRNSTrading Update
20th Apr 201112:40 pmRNSDirectorate Change
4th Apr 20119:56 amRNSDirectorate Change
23rd Mar 20112:55 pmRNSNPA - termination of recognition
4th Mar 201111:38 amRNSChange of Registered Office
14th Feb 20117:00 amRNSDirectorate Change
27th Jan 20117:00 amRNSTrading Update
9th Nov 20107:00 amRNSDirectorate Change
15th Sep 20107:00 amRNSDirector Declaration
15th Sep 20107:00 amRNSInterim Results - half year ended 30 June 2010
18th Aug 20107:00 amRNSTrading Update
13th Aug 201012:25 pmRNSDirector/PDMR Shareholding
19th May 20104:01 pmRNSResult of AGM
19th May 20107:00 amRNSAGM Statement
5th May 201010:55 amRNSAnnual Report Published
30th Apr 20107:00 amRNSSettlement of Litigation
29th Apr 20101:30 pmRNSre RNS announcement
29th Apr 20107:00 amRNSSettlement of Litigation
29th Mar 20104:44 pmRNSDirectors' Dealings and Options Exercise
24th Mar 20107:00 amRNSFinal Results
2nd Feb 20107:00 amRNSAcquisition
29th Jan 20107:00 amRNSTrading Statement
16th Dec 200912:05 pmRNSHolding(s) in Company
19th Nov 20094:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.